RA Capital Management Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 31
Professionals
  • Investments
  • 190
  • Portfolio
  • 70
  • Exits
  • 108
Exits

RA Capital Management General Information

Description

Founded in 2001, RA Capital Management is a venture capital firm and is based in Boston, Massachusetts. The firm focuses on evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices, and diagnostics. The firm also manages hedge funds.

Contact Information

Website
Year Founded
2001
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Hedge Fund
Primary Office
  • 200 Berkeley Street
  • 18th Floor
  • Boston, MA 02116
  • United States
+1 (617) 000-0000

RA Capital Management Investments & Acquisitions (190)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
T-Knife 06-Aug-2020 Early Stage VC 000.00 Drug Discovery Clinical Trials - Phase 1 000000 0000000 00
00000000 05-Aug-2020 0000 00000 0000 Drug Discovery Startup
000 000000 03-Aug-2020 00000 00000 0000 Drug Discovery Generating Revenue
0000000 0000000000 30-Jul-2020 0000 00000 Drug Discovery Generating Revenue
000000 000000 17-Jul-2020 0000 00000 Drug Discovery Generating Revenue
000000 13-Jul-2020 0000 000.00 Drug Discovery Generating Revenue/Not Profitable
000 000000000 07-Jul-2020 00000 00000 00000 Drug Discovery Generating Revenue 000000 0000000 00
000000 00000000000 02-Jul-2020 00000 00000 000.00 Biotechnology Clinical Trials - Phase 1 000000 00000 00.0
Bolt Biotherapeutics 01-Jul-2020 Later Stage VC 000.00 Drug Discovery Generating Revenue
Artiva Biotherapeutics 26-Jun-2020 Early Stage VC 0000 Drug Discovery Startup 00000 0000000 00.0
You’re viewing 10 of 190 investments and acquisitions. Get the full list »
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RA Capital Management Exits (107)

Company Name Exit Date Exit Type Exit Size
Inozyme Pharma 24-Jul-2020 IPO 00000
00000 000000000000 24-Jul-2020 000 00000
0000000 0000000000 17-Jul-2020 000 00000
000000 00000000000 13-Jul-2020 000 00000
00000 08-Jul-2020 000000 0000000000 000.00
000000 26-Jun-2020 000 00000
00000 000000000000 19-Jun-2020 000 00000
0000000 12-Jun-2020 000 00000
Legend Biotech 05-Jun-2020 IPO 00000
Lyra Therapeutics 01-May-2020 IPO 0000
You’re viewing 10 of 107 exits. Get the full list »

RA Capital Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

RA Capital Management Team (57)

Name Title Deals Funds Boards Office
Kai Wu Chief Financial Officer Boston, MA
Amanda Daniels Chief Operating Officer Boston, MA
Andrew Levin Ph.D Managing Director 00 0 0 Boston, MA
Peter Kolchinsky Ph.D Founder & Managing Partner 00 0 0 Boston, MA
Rajeev Shah Managing Partner 00 0 0 Boston, MA
You’re viewing 5 of 57 team members. Get the full list »

RA Capital Management Co-Investors (269)

Name With Exits Lead Partner Series Industry
Cormorant Asset Management 13 0 0 Series chart Industry bar
OrbiMed 00 0 00 Series chart Industry bar
Perceptive Advisors 00 0 0 Series chart Industry bar
Janus Henderson Investors 00 0 0 Series chart Industry bar
Foresite Capital Management 0 0 0 Series chart Industry bar
You’re viewing 5 of 269 co-investors. Get the full list »